Ironwood Pharma (IRWD) Reports Q2 Loss Per Share of 34c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. ABBV
5. CL
6. LYB
7. MRVL
8. TFII
9. SPY
10. AAPL

Go back to Ironwood Pharma (IRWD) Reports Q2 Loss Per Share of 34c, Offers Guidance

Ironwood Pharmaceuticals Provides Second Quarter 2015 Investor Update

August 5, 2015 4:01 PM EDT

LINZESS® (linaclotide) U.S. net sales of $112.1 million in second quarter 2015

Total LINZESS prescriptions increased approximately 56% in second quarter 2015 compared to second quarter 2014

Advanced innovative pipeline, including positive top-line Phase I data with sGC stimulator IW-1973

Entered agreement with Allergan to co-promote VIBERZI (eluxadoline) for IBS-D

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals,... More